Koshinski Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-3,934
Closed -$36.9K – 1829
2022
Q1
$36.9K Hold
3,934
– – ﹤0.01% 1225
2021
Q4
$31.5K Buy
3,934
+1,500
+62% +$13.5K ﹤0.01% 1313
2021
Q3
$23.7K Buy
+2,434
New +$22.8K ﹤0.01% 1399
2016
Q1
– Sell
-3,645
Closed -$239K – 244
2015
Q4
$239K Buy
3,645
+100
+3% +$6.18K 0.17% 173
2015
Q3
$210K Sell
3,545
-80
-2% -$5.19K 0.13% 208
2015
Q2
$214K Buy
3,625
+1
+0% +$62 0.14% 214
2015
Q1
$226K Hold
3,624
– – 0.15% 195
2014
Q4
$208K Buy
+3,624
New +$202K 0.12% 217

Other funds holding TEVA

Koshinski Asset Management's TEVA Position: Q2 2022 in Review

Koshinski Asset Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2022, closing a stake of 3,934 shares — an estimated $36.9K sold.

Koshinski Asset Management first reported a position in TEVA in Q4 2014 and held it in 8 quarters. The position peaked at $239K in Q4 2015. 456 funds tracked by Wall St. Rank hold TEVA as of Q2 2022.

  • Koshinski Asset Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 3,934 Teva Pharmaceutical Industries Limited shares in Q2 2022, an estimated $36.9K.
  • Koshinski Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q4 2014 and held it in 8 quarters.
  • Koshinski Asset Management's Teva Pharmaceutical Industries Limited position peaked at $239K in Q4 2015.
  • 456 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.